We are live on ! Find out more
IMOS icon

ChipMOS TECHNOLOGIES

51 hedge funds and large institutions have $64.6M invested in ChipMOS TECHNOLOGIES in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.22% less ownership

Funds ownership: 7.31% → 7.09% (-0.22%)

11% less funds holding

Funds holding: 57 → 51 (-6)

22% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 18

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

42% less capital inflows, than outflows

Capital inflows: $3.14M | Capital outflows: $5.4M

Holders
51
Holders Change
-6
Holders Change %
-10.53%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
14
Reduced
18
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IMOS Hedge Fund Activity: Q2 2022 in Review

51 of the 5,962 institutional investors tracked by Wall St. Rank reported a position in ChipMOS TECHNOLOGIES (IMOS) for Q2 2022, worth a combined $64.6M — down 32% from $94.4M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of IMOS and 8 opened new positions — a net loss of 5 holders — while 18 trimmed existing stakes and 14 added.

The largest buyer was Morgan Stanley, adding an estimated $977K. The largest seller was Goldman Sachs, exiting entirely with an estimated $662K sold.

  • 51 institutional investors held ChipMOS TECHNOLOGIES (IMOS) as of Q2 2022, down from 57 in Q1 2022.
  • Funds reported $64.6M of ChipMOS TECHNOLOGIES stock for Q2 2022, down 32% quarter-over-quarter.
  • 8 funds opened new ChipMOS TECHNOLOGIES positions in Q2 2022 and 13 closed out, a net change of -5 holders.
  • The largest ChipMOS TECHNOLOGIES buyer in Q2 2022 was Morgan Stanley, an estimated $977K added.
  • The largest ChipMOS TECHNOLOGIES seller in Q2 2022 was Goldman Sachs, an estimated $662K sold.

Based on aggregated 13F filings for Q2 2022.